Germany's MeVis Medical Solutions H1 revenue falls, cuts outlook

MeVis Medical Solutions AG

21/05/2026 14:01

Overview

Germany's medical imaging software firm reported fiscal H1 revenue declined yr/yr

Fiscal H1 EBIT dropped sharply, mainly due to lower revenue and higher personnel expenses

Company cut full-year revenue and EBIT forecasts on subdued mammography demand and screening delays

Outlook

MeVis now sees 2025/2026 revenue at €16.5 mln to €17.0 mln, down from €17.5 mln to €18.0 mln

Company expects 2025/2026 EBIT of €0.5 mln to €1.0 mln, lowered from €1.0 mln to €1.5 mln

Company cites subdued mammography demand and delayed lung cancer screening in Germany as factors

Result Drivers

HIGHER PERSONNEL EXPENSES - Co said consolidation of MeVis Breast Care led to increased personnel expenses, impacting EBIT

SUBDUED MAMMOGRAPHY DEMAND - Co cited subdued demand in the mammography sector for customer Hologic as reason for lower revenue forecast

SCREENING DELAYS - Co said delayed implementation of lung cancer screening in Germany is contributing to lower revenue forecast

Company press release: ID:nEQ8lf4Xsa

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
H1 Revenue
EUR 7.86 mln
H1 EBIT
EUR 160,000


Analyst Coverage

The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 12 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)